| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/20/2000 | WO2000021524A1 Pufa supplements |
| 04/20/2000 | WO2000021512A2 Composition and method for treating allergic diseases |
| 04/20/2000 | WO2000008463A3 Immunoadsorber for removing endotoxins |
| 04/20/2000 | WO1999066065A3 Proteasomal activity |
| 04/20/2000 | WO1999066037A3 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |
| 04/20/2000 | WO1999058658A3 Expression vectors for stimulating an immune response and methods of using the same |
| 04/20/2000 | WO1999057266A3 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 04/20/2000 | WO1999048868A9 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 04/20/2000 | DE19847968A1 Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit. |
| 04/20/2000 | DE19847114A1 Use of proteolytic enzymes to modulate hyperactive T cells, especially for symptomatic treatment of immune-mediated inflammatory diseases, e.g. multiple sclerosis, diabetes, arthritis or glomerulonephritis |
| 04/20/2000 | DE19843793A1 Substituierte Benzamide Substituted benzamides |
| 04/20/2000 | CA2653503A1 The use of ara as a supplement for a lactating woman |
| 04/20/2000 | CA2347653A1 Novel cell signaling polypeptides and nucleic acids |
| 04/20/2000 | CA2347113A1 Human ankyrin family protein |
| 04/20/2000 | CA2346943A1 Cyclic tetrapeptide compound and use thereof |
| 04/20/2000 | CA2346929A1 A modified polypeptide with reduced immune response |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346542A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity |
| 04/20/2000 | CA2346414A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | CA2346228A1 Composition and method for treating allergic diseases |
| 04/20/2000 | CA2346227A1 Composition and method for treating allergic diseases |
| 04/20/2000 | CA2346155A1 Enzymatic synthesis of ssdna |
| 04/20/2000 | CA2346006A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | CA2344694A1 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 04/20/2000 | CA2344465A1 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | CA2326675A1 Isolated peptides which bind to hla-b35 molecules |
| 04/19/2000 | EP0993469A1 COMPOUNDS ENCODING THE PROTECTIVE M-LIKE PROTEIN OF $i(STREPTOCOCCUS EQUI) AND ASSAYS THEREFOR |
| 04/19/2000 | EP0993456A1 2-substituted 4,5-diaryl imidazoles |
| 04/19/2000 | EP0993455A1 POLYMORPHS OF 8-CHLORO-6, 11-DIHYDRO-11- (4-PIPERIDYLIDENE) -5H-BENZO 5,6] CYCLOHEPTA 1,2-b]PYRIDINE |
| 04/19/2000 | EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 04/19/2000 | EP0993439A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0993437A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0880524B1 Adenosin antagonists, method of preparing them and their use as drugs |
| 04/19/2000 | EP0711297B1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 04/19/2000 | EP0586520B1 Backbone modified oligonucleotide analogs |
| 04/19/2000 | CN1251134A Neurotrophic factor NNT-1 |
| 04/19/2000 | CN1251133A Bi or multifunctional molecules based on dendroaspin scaffold |
| 04/19/2000 | CN1251100A Method for making arylamino triazolopyridines |
| 04/19/2000 | CN1251091A New compound |
| 04/19/2000 | CN1251043A Use of protein extractable from animal organs for prepn. of medicaments for treatment of pathological conditions |
| 04/19/2000 | CN1250776A Heterodicyclic compound derivatives |
| 04/19/2000 | CN1250652A Compositions contg. benzoxazinone and nucleoside like materials |
| 04/19/2000 | CN1051548C Heterobicyclic derivatives, pharmaceutical compositions contg. same, mfg. method and use thereof |
| 04/18/2000 | US6051718 A phosphodiesterase enzyme inhibitor and a cytokine antagonist for treating allergic, atopic and inflammatory diseases inflammatory diseases |
| 04/18/2000 | US6051601 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists |
| 04/18/2000 | US6051577 N-7-heterocyclyl pyrrolo[2,3-D]pyrimidines and the use thereof |
| 04/18/2000 | US6051571 Methods for treating medical dysfunctions and diseases using furan nitrone compounds |
| 04/18/2000 | US6051559 Cloning and characterizing of genes associated with long-term memory |
| 04/18/2000 | US6051428 Transducing tumor cells with herpes simplex virus amplicon containing gene coding for cytokines, chemokines, cellular adhesion molecules, or costimulatory molecules which activate b or t-cells for transient expression of the protein |
| 04/18/2000 | US6051416 Methods for producing enhanced antigenic Helicobacter sp. |
| 04/18/2000 | US6051239 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/18/2000 | US6051232 Comprising allogenic chimeric major histocompatibility complex class i milecule; to induce tolerance to donor grafts when administered to the recipient at time of transplantation |
| 04/18/2000 | US6051228 Antibodies against human CD40 |
| 04/18/2000 | US6051227 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 04/13/2000 | WO2000020635A1 ANTISENSE MODULATION OF INTEGRIN α4 EXPRESSION |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020612A2 Therapeutically active proteins in plants |
| 04/13/2000 | WO2000020601A2 Polyketide synthase enzymes and recombinant dna constructs therefor |
| 04/13/2000 | WO2000020590A2 G-protein coupled receptor proteins |
| 04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
| 04/13/2000 | WO2000020575A1 Pollinosis-associated gene |
| 04/13/2000 | WO2000020458A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000020402A1 Chemical compounds |
| 04/13/2000 | WO2000020401A1 New bis-benzimidazoles |
| 04/13/2000 | WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | WO2000020396A1 Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins |
| 04/13/2000 | WO2000020378A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 04/13/2000 | WO2000020371A1 Prostaglandin receptor ligands |
| 04/13/2000 | WO2000020370A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | WO2000020039A1 Methods and adjuvants for stimulating mucosal immunity |
| 04/13/2000 | WO2000020032A1 RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY |
| 04/13/2000 | WO2000020030A1 Anti-inflammatory alpha2, beta1 integrin-related substances or antibodies |
| 04/13/2000 | WO2000020029A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 04/13/2000 | WO2000020028A1 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
| 04/13/2000 | WO2000020027A2 Methods for therapeutic vaccination |
| 04/13/2000 | WO2000019998A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | WO2000019988A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 04/13/2000 | WO2000019987A1 Mucosal originated drug delivery systems and animal applications |
| 04/13/2000 | WO2000019828A1 METHODS FOR GENERATING ANTIGEN-REACTIVE T CELLS $i(IN VITRO) |
| 04/13/2000 | WO2000002877A3 New pharmaceutically active compounds |
| 04/13/2000 | WO2000000608A3 Immune system molecules |
| 04/13/2000 | WO1999065924A3 Preparation and use of superior vaccines |
| 04/13/2000 | CA2346864A1 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
| 04/13/2000 | CA2346496A1 Novel th2-specific molecules and uses thereof |
| 04/13/2000 | CA2346452A1 Methods and adjuvants for stimulating mucosal immunity |
| 04/13/2000 | CA2346445A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | CA2346443A1 Prostaglandin receptor ligands |
| 04/13/2000 | CA2346339A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 04/13/2000 | CA2346333A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | CA2346040A1 New bis-benzimidazoles |
| 04/13/2000 | CA2346037A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | CA2346034A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
| 04/13/2000 | CA2345817A1 Novel methods for therapeutic vaccination |
| 04/13/2000 | CA2345808A1 Mucosal originated drug delivery systems and animal applications |
| 04/13/2000 | CA2345440A1 Genes differentially expressed in cancer cells to design cancer vaccines |